Market insanity hits MicroCap


Yesterday was huge in that market. We saw how the GameStop (GME) short squeeze was finally fizzling with the buying frenzy turning to full-blown liquidation, which sent GME stock below $50 or down nearly 50% on the day back to where it was trading on the Friday when Andrew Left capitulated to the r/wallstreetbets horde, a clear rotation was taking place.

Chart

And while the waves of ramping were initially diffused without a clear target, as the day progressed it emerged that the "reddit rebellion" was now targeting tiny biotech names (under $2 billion in market cap, hence illiquid enough where a group of retail day traders could leave quite a mark) which, while not having GME's absurd 140% short-to-float ratio, were also quite shorted. This is merely a continuation of what we observed earlier in the week.

As an example of just how sensitive the redditors (and any retail investors for that matter) have become, consider what happened after the close, when Jefferies health-care equity strategist Jared Holz spoke on CNBC, and said that the trio of Karyopharm Therapeutics (KPTI), Rocket Pharmaceuticals (RCKT) and Madrigal Pharmaceuticals (MDGL) could be on the Reddit hit list given their high short interest and recent lack of volatility.

Literally second later, these three stocks shot up, with KPTI rising as much as 27%, RCKT jumping as much as 15% and MDCL rose 12%.

fxsoriginal

That's all we needed to know because it was now quite clear which way the wind was blowing: as WSB rotates out of the purely most shorted names, they are trying to spark buying frenzies in not just shorted names but also illiquid, small cap biotechs which may or may not have been left for dead.

So in anticipation of what may be another torrid session today, here is a screen of the 25 most shorted biotechs trading on the Nasdaq and with a market cap below $2 billion, where we find names such as ATOS, CYCC, KPTI (mentioned above), KDMN (a name that Steve Cohen recently revealed a 5.3% position), VXRT (which exploded higher earlier this week), and various other names.

Chart

And while the "most shorted" biotech names have already ramped aggressively yesterday, the same could be said about the most-shorted Russell 3000 stocks before they exploded 3x higher in the next two days. Expect more Fireworks for sure!

Recommended Content


Recommended Content

Editors’ Picks

AUD/USD stands firm above 0.6500 with markets bracing for Aussie PPI, US inflation

AUD/USD stands firm above 0.6500 with markets bracing for Aussie PPI, US inflation

The Aussie Dollar begins Friday’s Asian session on the right foot against the Greenback after posting gains of 0.33% on Thursday. The AUD/USD advance was sponsored by a United States report showing the economy is growing below estimates while inflation picked up. The pair traded at 0.6518.

AUD/USD News

EUR/USD mired near 1.0730 after choppy Thursday market session

EUR/USD mired near 1.0730 after choppy Thursday market session

EUR/USD whipsawed somewhat on Thursday, and the pair is heading into Friday's early session near 1.0730 after a back-and-forth session and complicated US data that vexed rate cut hopes.

EUR/USD News

Gold soars as US economic woes and inflation fears grip investors

Gold soars as US economic woes and inflation fears grip investors

Gold prices advanced modestly during Thursday’s North American session, gaining more than 0.5% following the release of crucial economic data from the United States. GDP figures for the first quarter of 2024 missed estimates, increasing speculation that the US Fed could lower borrowing costs.

Gold News

Ethereum could remain inside key range as Consensys sues SEC over ETH security status

Ethereum could remain inside key range as Consensys sues SEC over ETH security status

Ethereum appears to have returned to its consolidating move on Thursday, canceling rally expectations. This comes after Consensys filed a lawsuit against the US SEC and insider sources informing Reuters of the unlikelihood of a spot ETH ETF approval in May.

Read more

Bank of Japan expected to keep interest rates on hold after landmark hike

Bank of Japan expected to keep interest rates on hold after landmark hike

The Bank of Japan is set to leave its short-term rate target unchanged in the range between 0% and 0.1% on Friday, following the conclusion of its two-day monetary policy review meeting for April. The BoJ will announce its decision on Friday at around 3:00 GMT.

Read more

Majors

Cryptocurrencies

Signatures